NASDAQ:ZY
Zymergen Inc.
- Stock
Last Close
2.43
18/10 20:00
Volume Today
2.35M
Avg: 1.04M
PE Ratio
−1.33
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|
average inventory | 3.60M - | 5.50M 52.90% | ||
average payables | 13.17M - | 8.76M 33.50% | ||
average receivables | 3.83M - | 3.85M 0.48% | ||
book value per share | -5.10 - | -7.59 48.87% | 5.50 172.47% | |
capex per share | -0.23 - | -0.18 24.88% | -0.45 157.04% | |
capex to depreciation | -1.50 - | -0.92 38.97% | -1.62 76.09% | |
capex to operating cash flow | 0.12 - | 0.08 34.18% | 0.11 43.75% | |
capex to revenue | -1.48 - | -1.29 12.81% | -2.00 54.56% | |
cash per share | 1.48 - | 2.16 45.53% | 5.20 141.29% | |
days of inventory on hand | 7.92 - | 21.38 169.89% | 31.59 47.75% | |
days payables outstanding | 50.65 - | 52.06 2.78% | 28.36 45.51% | |
days sales outstanding | 72.15 - | 126.56 75.40% | 67.25 46.86% | |
debt to assets | 3.19 - | 3.44 7.74% | 0.22 93.66% | |
debt to equity | -1.46 - | -1.41 3.17% | 0.28 119.78% | |
dividend yield | ||||
earnings yield | -0.06 - | -0.07 10.72% | -0.73 924.63% | |
enterprise value | 3.62B - | 3.56B 1.81% | 154.43M 95.66% | |
enterprise value over ebitda | -16.57 - | -15.29 7.69% | -0.47 96.91% | |
ev to operating cash flow | -18.52 - | -15.93 13.97% | -0.51 96.80% | |
ev to sales | 234.92 - | 267.74 13.97% | 9.22 96.56% | |
free cash flow per share | -2.23 - | -2.45 10.05% | -4.53 84.40% | |
free cash flow yield | -0.06 - | -0.07 10.05% | -0.68 937.74% | |
graham net net | -5.91 - | -8.49 43.63% | 3.74 144.04% | |
graham number | 16.66 - | 21.39 28.39% | 24.57 14.87% | |
income quality | 0.83 - | 0.85 3.08% | 0.84 1.79% | |
intangibles to total assets | 0.03 - | 0.05 85.64% | 0.09 75.08% | |
interest coverage | -80.57 - | -22.00 72.70% | -23.64 7.45% | |
interest debt per share | 0.83 - | 0.92 11.12% | 0.79 14.28% | |
inventory turnover | 46.07 - | 17.07 62.95% | 11.55 32.32% | |
invested capital | -0.16 - | -0.11 31.95% | 0.11 200.88% | |
market cap | 3.69B - | 3.69B 0% | 496.58M 86.53% | |
net current asset value | -561.47M - | -820.08M 46.06% | 293.44M 135.78% | |
net debt to ebitda | 0.30 - | 0.56 88.48% | 1.05 86.32% | |
net income per share | -2.42 - | -2.68 10.72% | -4.87 82.07% | |
operating cash flow per share | -2.00 - | -2.28 14.13% | -4.07 78.81% | |
payables turnover | 7.21 - | 7.01 2.70% | 12.87 83.53% | |
receivables turnover | 5.06 - | 2.88 42.99% | 5.43 88.18% | |
research and ddevelopement to revenue | 3.29 - | 6.84 107.93% | 9.50 38.96% | |
return on tangible assets | -1.07 - | -0.91 15.08% | -0.76 15.87% | |
revenue per share | 0.16 - | 0.14 13.85% | 0.23 66.31% | |
roe | 0.47 - | 0.35 25.63% | -0.89 351.23% | |
roic | 3.22 - | 1.89 41.41% | 1.36 27.91% | |
sales general and administrative to revenue | 3.97 - | 4.52 13.85% | 4.96 9.63% | |
shareholders equity per share | -5.10 - | -7.59 48.87% | 5.50 172.47% | |
stock based compensation to revenue | 0.26 - | 0.36 39.71% | 1.27 250.14% | |
tangible asset value | -506.18M - | -760.13M 50.17% | 359.31M 147.27% | |
tangible book value per share | -5.17 - | -7.76 50.17% | 4.84 162.37% | |
working capital | 54.32M - | 107.12M 97.21% | 333.80M 211.62% |
All numbers in USD (except ratios and percentages)